Article

B&L, ophthalmic community to fund breast cancer research

Bausch & Lomb (B&L) has committed to raise both awareness and funding up to $400,000 for Susan G. Komen for the Cure through sales of its ReNu MultiPlus solution and an online campaign at www.ReNuCares.com.

B&L will donate $1 for every ReNu coupon redeemed or unique code entered online, with a minimum guaranteed donation of $300,000. The company also will team up with the ophthalmic community in this initiative. By supplying U.S. eye-care professionals with in-office displays, $2.50-off coupons, and pink plastic lens cases for patient giveaways, B&L hopes to activate its core constituency in fighting the disease.

"I am proud to partner with B&L on this wonderful cause," said Rhonda Robinson, OD, of Ossip-Robinson Optometry, Indianapolis, and president of the organization Women of Vision. "I want to encourage the entire community to take this opportunity to act together in a substantial way to help eradicate breast cancer."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.